THERAPEUTIC PRODUCT EFFECT INCOMPLETE

Adverse reaction reported in 35,702 FDA reports across 26 drugs.

35,702
Total Reports
26
Drugs Involved
Secukinumab
Most Reported Drug

Drugs Associated with THERAPEUTIC PRODUCT EFFECT INCOMPLETE

Drugs where "THERAPEUTIC PRODUCT EFFECT INCOMPLETE" was reported as an adverse event.

# Drug Reports % of Total
1 Secukinumab 5,054
14.2%
2 Mepolizumab 5,004
14.0%
3 Tiotropium Bromide 3,847
10.8%
4 Budesonide / Formoterol Fumarate Dihydrate 2,960
8.3%
5 Ciclesonide 2,587
7.2%
6 Erenumab-Aooe 1,937
5.4%
7 Fluticasone Propionate / Salmeterol Xinafoate 1,935
5.4%
8 Budesonide 1,637
4.6%
9 Fluticasone Furoate / Vilanterol Trifenatate 1,529
4.3%
10 Ipratropium Bromide 1,285
3.6%
11 Nirmatrelvir / Ritonavir 1,077
3.0%
12 Risankizumab-Rzaa 961
2.7%
13 Fluticasone Furoate 777
2.2%
14 Mometasone 756
2.1%
15 Rimegepant 643
1.8%
16 Valbenazine 556
1.6%
17 Clotrimazole 430
1.2%
18 Drs Clotrimazole 429
1.2%
19 Family Wellness Clotrimazole 429
1.2%
20 Theophylline 403
1.1%
21 Liothyronine 321
0.9%
22 Bimekizumab 291
0.8%
23 Carboxymethylcellulose 244
0.7%
24 Crisaborole 219
0.6%
25 Naltrexone Hydrochloride / Bupropion Hydrochloride 210
0.6%
26 Umeclidinium 181
0.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused therapeutic product effect incomplete. Always consult your healthcare provider.